🏆 Total Health Panel — Comprehensive

What this panel can settle, and by what logic

At 60 to 100 markers the value stops being in any single result and moves into the pairs that disagree. A smaller panel cannot produce a disagreement because it only carries one half of each pair.

1. Creatinine against cystatin C. Creatinine is a muscle metabolite, so a heavily muscled man reads a falsely low eGFR and a sarcopenic one a falsely high result. Where the creatinine-based and Cystatin C with eGFR-based estimates disagree, the discordance itself carries information about which of the two to believe Wang 2023 — and only a panel carrying both can generate it.
2. LDL cholesterol against ApoB (Apolipoprotein B). A normal LDL cholesterol with a raised ApoB is the discordance that holds the residual risk: across 13,015 statin-treated adults over a median of 8 years, ApoB and non-HDL cholesterol reflected it better than LDL cholesterol Johannesen 2021. A Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) on its own reports one of the two and cannot show you the gap.
3. HbA1c (Hemoglobin A1c) against fasting glucose against Fasting Insulin. HbA1c integrates 8 to 12 weeks, a fasting glucose is one morning, and insulin moves years before either Krhač 2019. An HbA1c of 5.4% with a fasting insulin of 18 µIU/mL is early insulin resistance that both glycemic markers report as normal.

What it cannot settle, and what would

A hundred markers is still no imaging, and the liver is where that costs most. In middle-aged people with overweight and normal liver enzymes, MASLD was present in 42% van Son 2024; read the other way round, more than 80% of people with fatty liver have an ALT inside the reference interval Lonardo 2024. A clean organ-function block is not a clean liver, and what settles it is ultrasound or an Enhanced Liver Fibrosis (ELF) Test score.

“Hormones” in a bundle this size is a screen, not a workup. A TSH (Thyroid-Stimulating Hormone) with a Free T4 (Thyroxine) does not separate autoimmune thyroid disease from a stressed axis without Thyroid Antibodies (TPO + TgAb); a single morning Total Testosterone is not a diagnosis at any panel size Itkonen 2024; and an estradiol reported off a standard immunoassay is not usable at male concentrations Rosner 2013. If a hormone question is the reason you are buying, a targeted panel answers it better for less Livingston 2023.

It cannot answer a question about your bones, and after 50 that is the omission that matters. Vitamin D, calcium and PTH explain why density might be falling. They do not measure density, which is a DEXA scan Bhattoa 2025.

And it does not make the once-in-a-lifetime measurement for you. Lipoprotein(a) — Lp(a) is essentially genetic and worth exactly one draw ever; if the bundle you order does not list it, adding it here is the single best $30 on the invoice Johannesen 2021.

Draw conditions that decide whether the money is wasted

A big bundle is drawn badly more often than a targeted one, because nobody told the buyer it had conditions — and here a bad draw wastes $495 rather than $60.

1. Fast 9 to 12 hours. Fasting glucose and triglycerides move most with a meal, and a non-fasted triglyceride of 220 mg/dL turns the Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)'s calculated LDL into a number nobody should act on.
2. 7 to 10am if any hormone on the list matters to you. Testosterone falls across the day and is reported against a morning interval Livingston 2023. Women: days 2 to 5 of the cycle, or the estradiol and gonadotropins are being read against the wrong phase Casals 2023.
3. No biotin for 3 days. On a panel this wide the biotin-sensitive markers are not one result but a dozen — TSH, free T4, free T3, LH, FSH, prolactin, ferritin and 25-hydroxyvitamin D are commonly run on streptavidin-based platforms Li 2020, and supplement doses of 5,000 mcg and above sit far above the concentration at which the interference starts Balzer 2023.
4. Not within 2 weeks of an illness, or 48 hours of hard training. Inflammation lifts ferritin and hs-CRP together and makes the whole nutrient block unreadable at the moment it looks most reassuring Luo 2023.

How you would know it answered your question, and what each pattern means next

The failure mode of a 100-marker result is chasing the wrong flag. Read it in this order and act only on these.

• First, the four that predict outcomes: ApoB (Apolipoprotein B), HbA1c (Hemoglobin A1c), Fasting Insulin and hs-CRP (High-Sensitivity C-Reactive Protein). Everything else on the page is context for those four Johannesen 2021.
• Then anything flagged twice. Reference intervals are drawn to contain the central 95% of a healthy population, so on 100 markers a handful of out-of-range values is arithmetic rather than news. Two related markers moving the same way is a pattern; one is not Krhač 2019.
• eGFR under 60 mL/min/1.73m² with a normal Urinalysis, Routine: repeat it with Cystatin C with eGFR before accepting it, particularly if you carry a lot of muscle Wang 2023.
• ALT above 30 U/L in a man or 20 U/L in a woman: the next test is imaging, not a repeat of this panel van Son 2024.
• Everything acceptable: repeat in 12 months. The only two numbers here that move enough to be worth a quarterly look are ALT and HbA1c Lonardo 2024, and both average over 8 to 12 weeks, so a 6-week recheck is reading the same blood twice.

Sources read for these sections

• Wang Y, et al. Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR. Kidney Medicine 2023 · PMID 37753251
• Johannesen CDL, et al. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. Journal of the American College of Cardiology 2021 · PMID 33736827
• Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World Journal of Diabetes 2019 · PMID 30697366
• van Son KC, et al. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine (Baltimore) 2024 · PMID 38181294
• Lonardo A. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!. World Journal of Gastroenterology 2024 · PMID 38983954
• Itkonen O, et al. The European biological variation study (EuBIVAS): Biological variation data for testosterone, follicle stimulating hormone, prolactin, luteinizing hormone and dehydroepiandrosterone sulfate in men. Clinica Chimica Acta 2024 · PMID 38341016
• Rosner W, et al. Challenges to the measurement of estradiol: an endocrine society position statement. Journal of Clinical Endocrinology and Metabolism 2013 · PMID 23463657
• Bhattoa HP, et al. Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporosis International 2025 · PMID 40152990
• Livingston M, et al. Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management. Diagnostics (Basel) 2023 · PMID 38132234
• Casals G, et al. Recommendations for the measurement of sexual steroids in clinical practice. A position statement of SEQCML/SEEN/SEEP. Advances in Laboratory Medicine 2023 · PMID 37359897
• Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med 2020 · PMID 32445355
• Balzer AHA, et al. An Analysis of the Biotin-(Strept)avidin System in Immunoassays: Interference and Mitigation Strategies. Current Issues in Molecular Biology 2023 · PMID 37998726
• Luo H, et al. A Practical Guide to Adjust Micronutrient Biomarkers for Inflammation Using the BRINDA Method. Journal of Nutrition 2023 · PMID 36792034